Skip to Content

Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) and Alcohol/Food Interactions

There are 2 alcohol/food/lifestyle interactions with Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) which include:

Major

multivitamins with minerals bictegravir

Major Drug Interaction

Products that contain aluminum, calcium, iron, magnesium or other minerals such as antacids and supplements may interfere with the absorption of bictegravir and reduce its effectiveness in treating HIV infection. Additionally, it may lead to development of viral resistance to this and various other HIV medications that are currently used for treatment. When used with antacids, you should generally take bictegravir on an empty stomach at least two hours before the antacid. Avoid taking bictegravir simultaneously with, or 2 hours after, antacid dosing whenever possible. When used with multivitamin or mineral supplements, you may take bictegravir and supplements together at the same time, but with food. Avoid taking bictegravir on an empty stomach simultaneously with, or 2 hours after, dosing of supplements. Talk to your doctor or pharmacist if you have questions on how to take this or other medications you are prescribed, or if you have trouble separating the dosing times. Your doctor may be able to prescribe alternatives that do not interact. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Minor

tenofovir food

Minor Food Interaction

Information for this minor interaction is available on the professional version.

Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) drug interactions

There are 367 drug interactions with Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)

Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) disease interactions

There are 9 disease interactions with Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) which include:

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.